IRIS
VIAZZI, FRANCESCA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.933
AS - Asia 3.380
NA - Nord America 3.116
Continente sconosciuto - Info sul continente non disponibili 707
SA - Sud America 316
AF - Africa 59
OC - Oceania 10
Totale 32.521
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 24.346
US - Stati Uniti d'America 2.920
SG - Singapore 1.321
CN - Cina 849
VN - Vietnam 486
BD - Bangladesh 419
FR - Francia 239
BR - Brasile 185
HK - Hong Kong 118
FI - Finlandia 101
CA - Canada 74
DE - Germania 65
AR - Argentina 63
MX - Messico 40
IN - India 38
GB - Regno Unito 35
JP - Giappone 34
CH - Svizzera 25
IQ - Iraq 24
ID - Indonesia 22
CO - Colombia 18
NL - Olanda 18
EC - Ecuador 17
ZA - Sudafrica 16
JM - Giamaica 15
CR - Costa Rica 13
ES - Italia 12
RU - Federazione Russa 12
VE - Venezuela 12
IE - Irlanda 11
NI - Nicaragua 10
PK - Pakistan 10
AU - Australia 9
CL - Cile 9
PH - Filippine 8
PL - Polonia 8
UA - Ucraina 8
GT - Guatemala 7
HN - Honduras 7
MA - Marocco 7
SA - Arabia Saudita 7
DZ - Algeria 6
RO - Romania 6
SV - El Salvador 6
AT - Austria 5
DK - Danimarca 5
EG - Egitto 5
PY - Paraguay 5
SN - Senegal 5
TR - Turchia 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
PR - Porto Rico 4
SE - Svezia 4
TH - Thailandia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KR - Corea 3
LB - Libano 3
NG - Nigeria 3
PA - Panama 3
SC - Seychelles 3
AL - Albania 2
BB - Barbados 2
CI - Costa d'Avorio 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
LI - Liechtenstein 2
MK - Macedonia 2
MN - Mongolia 2
MT - Malta 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 31.799
Salva come PNG Salva come JPEG
Città #
Genova 12.477
Genoa 7.801
Vado Ligure 1.851
Rapallo 1.753
San Jose 699
Singapore 658
Ashburn 337
Lauterbourg 216
Council Bluffs 191
Ho Chi Minh City 152
Beijing 148
New York 142
Hong Kong 113
Hanoi 106
Helsinki 88
Santa Clara 84
Los Angeles 66
Boardman 49
Frankfurt am Main 46
Rome 46
Bordighera 43
Milan 42
St Louis 36
Buffalo 35
Dallas 32
Tokyo 28
Atlanta 24
Chicago 24
Mexico City 24
São Paulo 24
Orem 23
Zurich 23
Phoenix 22
Philadelphia 21
Haiphong 20
Naples 20
Brooklyn 18
Da Nang 17
Tianjin 17
The Bronx 16
Charlotte 15
Toronto 13
Kingston 12
Lappeenranta 12
Turin 12
Dublin 11
Las Vegas 11
Montreal 11
San Antonio 11
Amsterdam 10
Biên Hòa 10
Managua 10
San Francisco 10
Tampa 10
Chennai 9
Houston 9
London 9
San José 9
Boston 8
Buenos Aires 8
Detroit 8
Florence 8
Johannesburg 8
Nuremberg 8
Palermo 8
Stillwater 8
Baghdad 7
City of London 7
Columbus 7
Hải Dương 7
Rio de Janeiro 7
Shanghai 7
Bari 6
Bogotá 6
Bologna 6
Cincinnati 6
East Brunswick 6
Greensboro 6
Guangzhou 6
Jacksonville 6
Memphis 6
Miami 6
Mumbai 6
Paris 6
Quito 6
Sydney 6
Baltimore 5
Bắc Ninh 5
Cardiff 5
Charleston 5
Dakar 5
Denver 5
Des Moines 5
Guayaquil 5
Milwaukee 5
North Bergen 5
Princeton 5
Queens 5
Quảng Ngãi 5
Salt Lake City 5
Totale 27.986
Salva come PNG Salva come JPEG
Nome #
MicroRaman spectroscopy detects the presence of microplastics in human urine and kidney tissue 464
Homocysteine exchange across skeletal muscle in patients with chronic kidney disease 319
Left ventricular dilatation and subclinical renal damage in primary hypertension 265
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. 223
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 220
Interorgan handling of fibroblast growth factor-23 in humans 216
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 214
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 213
Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. 212
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 206
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 205
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 203
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 202
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 195
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 192
Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease 191
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 191
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 191
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 190
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 188
C-reactive protein and target organ damage in untreated patients with primary hypertension. 186
#6111 FIRST IDENTIFICATION AND CHARACTERIZATION OF MICROPLASTICS IN HUMAN KIDNEY AND URINE 185
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 184
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 182
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 181
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 181
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 180
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 180
Cardiovascular and renal effects of hyperuricaemia and gout. 179
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 179
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 177
The Organ Handling of Soluble Klotho in Humans 176
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 175
Renal and cardiac abnormalities in primary hypertension 174
Novelty in hypertension in children and adolescents: Focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors 174
Blood pressure variability and multiple organ damage in primary hypertension 172
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 171
The control of muscle protein turnover in patients on peritoneal dialys 170
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 170
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 170
Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria 169
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 168
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 165
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 165
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 164
Microalbuminuria in primary hypertension: a guide to optimal patient management? 162
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 160
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 159
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 158
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 158
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 158
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis 158
Creatinine clearance and early signs of target organ damage in primary hypertension 157
Sub-clinical organ damage in hypertension and obesity 157
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 155
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 154
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 154
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 154
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 153
Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports 152
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 152
We are far from achieving blood pressure goals in diabetes: Do we really want to do it? 152
Albuminuria: The kidney message on cardiovascular health 151
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 151
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 151
Hyperuricemia and renal risk 151
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 151
Mild renal dysfunction and renal vascular resistance in primary hypertension 150
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 149
Serum uric acid and risk of CKD in type 2 diabetes 148
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 148
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 148
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 146
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 146
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 145
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 144
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 143
Overall health assessment: a renal perspective. 143
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 143
Chronic kidney disease and albuminuria in arterial hypertension. 143
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 142
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 142
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 142
Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes 142
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 141
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 140
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 139
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 139
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 139
Serum uric acid as a marker of target organ damage in primary hypertension 138
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 138
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 138
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 137
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 137
Diabetic kidney disease in the elderly: Prevalence and clinical correlates 137
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 136
Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative 136
Antihypertensive therapy in hypertensive patients with metabolic syndrome. 134
RAAS Inhibition and Renal Protection 134
Totale 17.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.924
article - articoli 104.183
book - libri 0
conference - conferenze 844
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.897
Totale 213.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.261 98 98 107 231 90 236 130 528 130 253 81 279
2022/20232.159 206 139 20 229 325 378 31 173 380 29 209 40
2023/20241.498 68 162 43 191 125 277 94 103 64 35 110 226
2024/20255.367 139 326 192 320 610 480 442 759 204 338 585 972
2025/20269.680 941 338 760 844 1.032 733 1.389 434 632 1.024 682 871
2026/2027887 887 0 0 0 0 0 0 0 0 0 0 0
Totale 32.521